[Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000648:ultrastructure; D000368:Aged; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000648:ultrastructure
D004273:DNA, Neoplasm; D008525:Medroxyprogesterone
Effetti del trattamento orale con 6-metil-17-idrossiprogesterone acetato (MAP) nell'adenocarcinoma dell'endometrio.